Protein Tyrosine Phosphatases in Cancer

[1]  M. Delepierre,et al.  Regulation of the catalytic activity of the human phosphatase PTPN4 by its PDZ domain , 2014, The FEBS journal.

[2]  K. Wen,et al.  Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low-grade squamous intraepithelial lesions - a Taiwanese Gynecologic Oncology Group (TGOG) study. , 2014, Gynecologic oncology.

[3]  D. Alvaro,et al.  PTPN3 mutations and HBV may exert synergistic effects in the origin of the intrahepatic cholangiocarcinoma. , 2014, Gastroenterology.

[4]  Q. Pang,et al.  The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes , 2014, Cell Research.

[5]  R. Zamoyska,et al.  The tyrosine phosphatase Ptpn22 discriminates weak, self-peptide from strong agonist T cell receptor signals , 2014, Nature Immunology.

[6]  N. Yang,et al.  PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function* , 2014, The Journal of Biological Chemistry.

[7]  Kuen-Feng Chen,et al.  SHP-1 is a target of regorafenib in colorectal cancer , 2014, Oncotarget.

[8]  Xiaojun Zhu,et al.  Protein tyrosine phosphatase PTPN9 regulates erythroid cell development through STAT3 dephosphorylation in zebrafish , 2014, Journal of Cell Science.

[9]  Eric D. Wieben,et al.  Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers , 2014, BMC Medical Genomics.

[10]  W. Hendriks,et al.  Protein tyrosine phosphatase receptor type R deficient mice exhibit increased exploration in a new environment and impaired novel object recognition memory , 2014, Behavioural Brain Research.

[11]  Xianghuo He,et al.  Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients. , 2014, Gastroenterology.

[12]  K. Friedrich,et al.  Protein tyrosine phosphatases as wardens of STAT signaling. , 2014, JAK-STAT.

[13]  F. Pontén,et al.  PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas , 2014, Tumor Biology.

[14]  Cheng-Chang Chang,et al.  ATL , 2014, International Journal of Gynecologic Cancer.

[15]  Kuen-Feng Chen,et al.  Discovery of novel src homology region 2 domain‐containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma , 2014, Hepatology.

[16]  A. Thorburn,et al.  Autophagy variation within a cell population determines cell fate via selective degradation of Fap-1 , 2013, Nature Cell Biology.

[17]  W. Wei,et al.  Colorectal cancer susceptibility variants alter risk of breast cancer in a Chinese Han population. , 2013, Genetics and molecular research : GMR.

[18]  Wei Zhang,et al.  The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma. , 2013, Experimental and molecular pathology.

[19]  Sung Goo Park,et al.  Role of Protein Tyrosine Phosphatase Non-Receptor Type 7 in the Regulation of TNF-α Production in RAW 264.7 Macrophages , 2013, PloS one.

[20]  Lin Feng,et al.  Defining the Protein–Protein Interaction Network of the Human Hippo Pathway* , 2013, Molecular & Cellular Proteomics.

[21]  Wei Zhang,et al.  Stat3 Inhibits PTPN13 Expression in Squamous Cell Lung Carcinoma through Recruitment of HDAC5 , 2013, BioMed research international.

[22]  S. Brier,et al.  The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis , 2013, Oncogene.

[23]  John H. Lee,et al.  Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex. , 2013, Cancer research.

[24]  Y. Ono,et al.  Necl-2/CADM1 interacts with ErbB4 and regulates its activity in GABAergic neurons , 2013, Molecular and Cellular Neuroscience.

[25]  A. Irrthum,et al.  Mutations in the VEGFR3 Signaling Pathway Explain 36% of Familial Lymphedema , 2013, Molecular Syndromology.

[26]  P. Darcy,et al.  Gene-engineered T cells for cancer therapy , 2013, Nature Reviews Cancer.

[27]  T. Hara,et al.  Tumor-suppressive Function of Protein-tyrosine Phosphatase Non-receptor Type 23 in Testicular Germ Cell Tumors Is Lost upon Overexpression of miR142–3p microRNA* , 2013, The Journal of Biological Chemistry.

[28]  B. Neel,et al.  Shp1 regulates T cell homeostasis by limiting IL-4 signals , 2013, The Journal of experimental medicine.

[29]  J. Boehm,et al.  A ‘danse macabre’: tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity , 2013, The European journal of neuroscience.

[30]  Juan Zhou,et al.  PTPN4 negatively regulates CrkI in human cell lines , 2013, Cellular & Molecular Biology Letters.

[31]  M. Pagano,et al.  FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade , 2013, Nature Cell Biology.

[32]  W. Sellers,et al.  The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity , 2013, PloS one.

[33]  C. Castilla,et al.  PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells , 2013, Cell Death and Disease.

[34]  B. Neel,et al.  Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. , 2013, Immunity.

[35]  E. Eklund,et al.  Fas-associated Phosphatase 1 (Fap1) Influences βCatenin Activity in Myeloid Progenitor Cells Expressing the Bcr-abl Oncogene , 2013, The Journal of Biological Chemistry.

[36]  P. Woodman,et al.  Recruitment of UBPY and ESCRT Exchange Drive HD-PTP-Dependent Sorting of EGFR to the MVB , 2013, Current Biology.

[37]  R. Askeland,et al.  MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling , 2013, Journal of Cell Science.

[38]  N. Yang,et al.  PTPN14 interacts with and negatively regulates the oncogenic function of YAP , 2013, Oncogene.

[39]  E. Eklund,et al.  Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr–abl oncogene , 2013, Leukemia & lymphoma.

[40]  H. Lai,et al.  Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer , 2013, Oncogene.

[41]  M. Bębenek,et al.  Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer , 2012, Journal of Human Genetics.

[42]  Hua Tang,et al.  Tyrosine phosphatase PTP-MEG2 negatively regulates vascular endothelial growth factor receptor signaling and function in endothelial cells. , 2012, American journal of physiology. Cell physiology.

[43]  Junjie Chen,et al.  PTPN14 is required for the density-dependent control of YAP1. , 2012, Genes & development.

[44]  K. Lan,et al.  Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice , 2012, PloS one.

[45]  Thomas M. Schmitt,et al.  Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo , 2012, The Journal of Immunology.

[46]  B. Lerer,et al.  Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition , 2012, Psychiatric genetics.

[47]  K. Siminovitch,et al.  Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance , 2012, Diabetes.

[48]  R. Negro,et al.  Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. , 2012, Blood.

[49]  Songwang Hou,et al.  p38γ Mitogen-activated Protein Kinase Signals through Phosphorylating Its Phosphatase PTPH1 in Regulating Ras Protein Oncogenesis and Stress Response* , 2012, The Journal of Biological Chemistry.

[50]  B. Karlan,et al.  YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14 , 2012, Oncogene.

[51]  P. Kim,et al.  Discovery of ALK‐PTPN3 gene fusion from human non‐small cell lung carcinoma cell line using next generation RNA sequencing , 2012, Genes, chromosomes & cancer.

[52]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[53]  Michael A. Freitas,et al.  Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals. , 2012, Cancer cell.

[54]  S. Castiglioni,et al.  The tyrosine phosphatase HD-PTP (PTPN23) is degraded by calpains in a calcium-dependent manner. , 2012, Biochemical and biophysical research communications.

[55]  S. Markowitz,et al.  Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase non-receptor 14 , 2012, Oncogene.

[56]  J. den Hertog,et al.  Pair-Wise Regulation of Convergence and Extension Cell Movements by Four Phosphatases via RhoA , 2012, PloS one.

[57]  Inmoo Rhee,et al.  Protein tyrosine phosphatases in lymphocyte activation and autoimmunity , 2012, Nature Immunology.

[58]  M. Weinblatt,et al.  PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis , 2012, PloS one.

[59]  R. Baumgartner,et al.  Drosophila Pez Acts in Hippo Signaling to Restrict Intestinal Stem Cell Proliferation , 2012, Current Biology.

[60]  Z. Zhao,et al.  Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer , 2012, Breast Cancer Research.

[61]  G. Viglietto,et al.  The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer. , 2012, The American journal of pathology.

[62]  H. Kalthoff,et al.  Characterisation of FAP-1 expression and CD95 mediated apoptosis in the A818-6 pancreatic adenocarcinoma differentiation system. , 2012, Differentiation; research in biological diversity.

[63]  T. Mustelin,et al.  Inhibition of Hematopoietic Protein Tyrosine Phosphatase Augments and Prolongs ERK1/2 and p38 Activation , 2012, ACS chemical biology.

[64]  Kerang Zhang,et al.  Gender-specific role of the protein tyrosine phosphatase receptor type R gene in major depressive disorder. , 2012, Journal of affective disorders.

[65]  B. Lie,et al.  LYP inhibits T cell activation when dissociated from CSK , 2012, Nature chemical biology.

[66]  C. Castilla,et al.  Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells , 2012, Clinical & Experimental Metastasis.

[67]  Haifeng Zhao,et al.  Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis , 2012, Medical Oncology.

[68]  E. Eklund,et al.  The Leukemia-associated Fusion Protein Tel-Platelet-derived Growth Factor Receptor β (Tel-PdgfRβ) Inhibits Transcriptional Repression of PTPN13 Gene by Interferon Consensus Sequence Binding Protein (Icsbp) , 2012, The Journal of Biological Chemistry.

[69]  G. Bhanot,et al.  ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers , 2012, PloS one.

[70]  E. L. Luning Prak,et al.  Altered B Cell Homeostasis Is Associated with Type I Diabetes and Carriers of the PTPN22 Allelic Variant , 2012, The Journal of Immunology.

[71]  Kuen-Feng Chen,et al.  Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. , 2011, Journal of hepatology.

[72]  Lei Zhang,et al.  Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance. , 2011, Journal of genetics and genomics = Yi chuan xue bao.

[73]  M. Delepierre,et al.  Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death. , 2011, Structure.

[74]  T. Xiao,et al.  The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release. , 2011, Structure.

[75]  G. Travé.  PDZ-peptide complexes: as exciting as ever. , 2011, Structure.

[76]  Joshua M. Korn,et al.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.

[77]  N. Zaffaroni,et al.  Interplay between Ret and Fap-1 regulates CD95-mediated apoptosis in medullary thyroid cancer cells. , 2011, Biochemical pharmacology.

[78]  K. Siminovitch,et al.  The autoimmune disease–associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness , 2011, Nature Genetics.

[79]  P. Gregersen,et al.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. , 2011, The Journal of clinical investigation.

[80]  Zhongming Zhao,et al.  Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia , 2011, Schizophrenia Research.

[81]  Wei Wang,et al.  Crystal structure of human protein tyrosine phosphatase SHP‐1 in the open conformation , 2011, Journal of cellular biochemistry.

[82]  M. Garcia-Marcos,et al.  Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates Gα-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway* , 2011, The Journal of Biological Chemistry.

[83]  N. Tonks,et al.  Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'. , 2011, Genes & development.

[84]  M. Picciotto,et al.  Striatal‐enriched protein tyrosine phosphatase (STEP) knockout mice have enhanced hippocampal memory , 2011, The European journal of neuroscience.

[85]  K. Moberg,et al.  A screen for conditional growth suppressor genes identifies the Drosophila homolog of HD-PTP as a regulator of the oncoprotein Yorkie. , 2011, Developmental cell.

[86]  W. Hong,et al.  The hippo pathway in biological control and cancer development , 2011, Journal of cellular physiology.

[87]  T. Glant,et al.  Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans. , 2011, The American journal of pathology.

[88]  J. Sekine,et al.  FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis. , 2011, International journal of oral and maxillofacial surgery.

[89]  B. Neel,et al.  Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2. , 2011, Biochemistry.

[90]  C. Lowell.  Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. , 2011, Cold Spring Harbor perspectives in biology.

[91]  O. Witte,et al.  Regulated expression of microRNAs-126/126* inhibits erythropoiesis from human embryonic stem cells. , 2011, Blood.

[92]  R. Page,et al.  Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loop. , 2011, Journal of molecular biology.

[93]  M. Jaggi,et al.  Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene‐induced upregulation of HPV E7 , 2011, Molecular carcinogenesis.

[94]  C. Tanase.  Histidine Domain-Protein Tyrosine Phosphatase Interacts with Grb2 and GrpL , 2010, PloS one.

[95]  L. Banks,et al.  A Systematic Analysis of Human Papillomavirus (HPV) E6 PDZ Substrates Identifies MAGI-1 as a Major Target of HPV Type 16 (HPV-16) and HPV-18 Whose Loss Accompanies Disruption of Tight Junctions , 2010, Journal of Virology.

[96]  I. Leigh,et al.  Tyrosine dephosphorylation is required for Bak activation in apoptosis , 2010, The EMBO journal.

[97]  Rong-shan Li,et al.  PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization , 2010, Oncogene.

[98]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[99]  L. Insabato,et al.  PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells* , 2010, The Journal of Biological Chemistry.

[100]  Jong-Young Lee,et al.  Genetic variants that affect length/height in infancy/early childhood in Vietnamese-Korean families , 2010, Journal of Human Genetics.

[101]  B. Gelb,et al.  Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. , 2010, American journal of human genetics.

[102]  Theresa Zhang,et al.  Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors , 2010, Science Translational Medicine.

[103]  J. Connor,et al.  NR2B‐NMDA receptor‐mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling , 2010, Journal of neurochemistry.

[104]  Zchong‐Zcho Wu,et al.  Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells. , 2010, Biochemical pharmacology.

[105]  Sun-Mi Park,et al.  miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. , 2010, Molecular cell.

[106]  E. Borden,et al.  Novel SHP-1 Inhibitors Tyrosine Phosphatase Inhibitor-1 and Analogs with Preclinical Anti-Tumor Activities as Tolerated Oral Agents , 2010, The Journal of Immunology.

[107]  J. Dixon,et al.  Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer , 2010, Breast Cancer Research and Treatment.

[108]  Paul Greengard,et al.  Aβ-Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP61 , 2010, The Journal of Neuroscience.

[109]  Huiqing Liu,et al.  Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma , 2010, BMC Systems Biology.

[110]  E. Villa-Moruzzi,et al.  Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[111]  Rong-shan Li,et al.  PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction. , 2010, Cancer research.

[112]  Yongping Wang,et al.  Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells* , 2010, The Journal of Biological Chemistry.

[113]  S. Toyooka,et al.  Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers , 2010, Journal of Cancer Research and Clinical Oncology.

[114]  M. Delepierre,et al.  Attenuation of Rabies Virulence: Takeover by the Cytoplasmic Domain of Its Envelope Protein , 2010, Science Signaling.

[115]  I. Amelio,et al.  Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors , 2010, Oncology.

[116]  Wei Wu,et al.  Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin. , 2010, World journal of gastroenterology.

[117]  Josef Jiricny,et al.  The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis , 2009, Molecular Cancer.

[118]  Q. Wei,et al.  Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. , 2009, Carcinogenesis.

[119]  A. Pozzi,et al.  Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity. , 2009, Blood.

[120]  L. Fajas,et al.  Downregulation of protein tyrosine phosphatase PTP-BL represses adipogenesis. , 2009, The international journal of biochemistry & cell biology.

[121]  X. Montano,et al.  Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation , 2009, Oncogene.

[122]  R. Heumann,et al.  PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells , 2009, Journal of Cell Science.

[123]  T. Kipps,et al.  Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. , 2009, Cancer cell.

[124]  A. Bossler,et al.  Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling via the MAP kinase pathway , 2009, Oncogene.

[125]  Michio Inoue,et al.  Divergent Bro1 Domains Share the Capacity To Bind Human Immunodeficiency Virus Type 1 Nucleocapsid and To Enhance Virus-Like Particle Production , 2009, Journal of Virology.

[126]  D. Centonze,et al.  A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum , 2009, Biological Psychiatry.

[127]  S. Knapp,et al.  HD-PTP Is a Catalytically Inactive Tyrosine Phosphatase Due to a Conserved Divergence in Its Phosphatase Domain , 2009, PloS one.

[128]  Y. Tu,et al.  Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle , 2009, The Journal of cell biology.

[129]  M. Bouchard,et al.  Expression analysis and essential role of the putative tyrosine phosphatase His-domain-containing protein tyrosine phosphatase (HD-PTP). , 2009, The International journal of developmental biology.

[130]  S. Castiglioni,et al.  HD-PTP inhibits endothelial migration through its interaction with Src. , 2009, The international journal of biochemistry & cell biology.

[131]  M. Hermiston,et al.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells , 2009, Immunological reviews.

[132]  F. Révillion,et al.  Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer , 2009, International journal of cancer.

[133]  J. Rudolph,et al.  Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines. , 2009, Biochemistry.

[134]  Wen Hwa Lee,et al.  Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome , 2009, Cell.

[135]  B. Kremer,et al.  PTPRR Protein Tyrosine Phosphatase Isoforms and Locomotion of Vesicles and Mice , 2009, The Cerebellum.

[136]  S. Castiglioni,et al.  Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTP. , 2009, Cancer letters.

[137]  M. Picciotto,et al.  Knockout of STriatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation , 2009, Synapse.

[138]  P. King,et al.  The FERM and PDZ Domain-Containing Protein Tyrosine Phosphatases, PTPN4 and PTPN3, Are Both Dispensable for T Cell Receptor Signal Transduction , 2008, PloS one.

[139]  W. Peti,et al.  Structural basis of substrate recognition by hematopoietic tyrosine phosphatase. , 2008, Biochemistry.

[140]  B. Beutler,et al.  Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger (Proceedings of the National Academy of Sciences of the United States of America (2008) 105, 39, (15028-15033) DOI: 10.1073/pnas.0806619105) , 2008 .

[141]  Yan P. Yuan,et al.  Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability , 2008, BMC Cancer.

[142]  W. Marasco,et al.  Mechanisms of SHP‐1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV‐1‐transformed T cells , 2008, Journal of leukocyte biology.

[143]  C. Patrignani,et al.  Knockout mice reveal a role for protein tyrosine phosphatase H1 in cognition , 2008, Behavioral and Brain Functions.

[144]  Amy M Becker,et al.  The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions. , 2008, Molecular immunology.

[145]  B. Aggarwal,et al.  Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. , 2008, Cancer research.

[146]  Jean-Yves Roignant,et al.  Myopic acts in the endocytic pathway to enhance signaling by the Drosophila EGF receptor , 2008, Development.

[147]  Aleksandr Mironov,et al.  The Bro1-related protein HD-PTP/PTPN23 is required for endosomal cargo sorting and multivesicular body morphogenesis , 2008, Proceedings of the National Academy of Sciences.

[148]  L. Nezi,et al.  Protein-tyrosine Phosphatase PTPD1 Regulates Focal Adhesion Kinase Autophosphorylation and Cell Migration* , 2008, Journal of Biological Chemistry.

[149]  J. Yates,et al.  Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling , 2008, Oncogene.

[150]  Ping-yuan Wang,et al.  The N Terminus Controls Sterol Binding while the C Terminus Regulates the Scaffolding Function of OSBP* , 2008, Journal of Biological Chemistry.

[151]  Chunliu Zhu,et al.  The Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Represses PTPN13 Gene Transcription in Differentiating Myeloid Cells* , 2008, Journal of Biological Chemistry.

[152]  O. Abaan,et al.  PTPL1: a large phosphatase with a split personality , 2008, Cancer and Metastasis Reviews.

[153]  T. Mustelin,et al.  IMMUNOHISTOCHEMICAL ANALYSES OF PHOSPHATASES IN CHILDHOOD B-CELL LYMPHOMA: Lower Expression of PTEN and HePTP and Higher Number of Positive Cells for Nuclear SHP2 in B-Cell Lymphoma Cases Compared to Controls , 2008, Pediatric hematology and oncology.

[154]  G. F. Harris,et al.  The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth , 2007, Journal of Virology.

[155]  S. Castiglioni,et al.  The tyrosine phosphatase HD-PTP: A novel player in endothelial migration. , 2007, Biochemical and biophysical research communications.

[156]  Andy Hudmon,et al.  Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases , 2007, Proceedings of the National Academy of Sciences.

[157]  A. Frey,et al.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells. , 2007, Cancer research.

[158]  C. Rommel,et al.  Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth* , 2007, Journal of Biological Chemistry.

[159]  M. Scheffner,et al.  Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses. , 2007, The Journal of general virology.

[160]  H. Allgayer,et al.  Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model , 2007, British Journal of Cancer.

[161]  M. Kano,et al.  Involvement of protein‐tyrosine phosphatase PTPMEG in motor learning and cerebellar long‐term depression , 2007, The European journal of neuroscience.

[162]  Y. Khew-Goodall,et al.  The protein tyrosine phosphatase Pez regulates TGFβ, epithelial–mesenchymal transition, and organ development , 2007, The Journal of cell biology.

[163]  J. Kutok,et al.  B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. , 2007, Immunity.

[164]  Gilles Freiss,et al.  The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation. , 2007, Cancer research.

[165]  U. Lorenz,et al.  Identification of a Novel Lipid Raft-Targeting Motif in Src Homology 2-Containing Phosphatase 11 , 2007, The Journal of Immunology.

[166]  A. Ostman,et al.  Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2. , 2007, Free radical biology & medicine.

[167]  Chiu-Jung Huang,et al.  Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3. , 2007, Journal of Biomedical Sciences.

[168]  T. Mustelin,et al.  Association of Protein-tyrosine Phosphatase MEG2 via Its Sec14p Homology Domain with Vesicle-trafficking Proteins* , 2007, Journal of Biological Chemistry.

[169]  J. Cheung,et al.  Regulation of TRP channel TRPM2 by the tyrosine phosphatase PTPL1. , 2007, American journal of physiology. Cell physiology.

[170]  K. Siminovitch,et al.  Nonreceptor protein-tyrosine phosphatases in immune cell signaling. , 2007, Annual review of immunology.

[171]  T. Mustelin,et al.  Normal TCR Signal Transduction in Mice That Lack Catalytically Active PTPN3 Protein Tyrosine Phosphatase1 , 2007, The Journal of Immunology.

[172]  P. Włodarski,et al.  PU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells* , 2007, Journal of Biological Chemistry.

[173]  M. Nakahira,et al.  Regulation of signal transducer and activator of transcription signaling by the tyrosine phosphatase PTP-BL. , 2007, Immunity.

[174]  P. Garrity,et al.  Ptpmeg is required for the proper establishment and maintenance of axon projections in the central brain of Drosophila , 2007, Development.

[175]  W. Marasco,et al.  Negative regulation of the SH2-homology-containing protein-tyrosine phosphatase-1 (Shp-1) P2 promoter by the HTLV-1 tax oncoprotein , 2006, Retrovirology.

[176]  M. Kinter,et al.  Degradation of Tyrosine Phosphatase PTPN3 (PTPH1) by Association with Oncogenic HumanPapillomavirus E6 Proteins , 2006, Journal of Virology.

[177]  W. Hendriks,et al.  Altered MAP kinase phosphorylation and impaired motor coordination in PTPRR deficient mice , 2006, Journal of neurochemistry.

[178]  P. Jansen,et al.  Tyrosine-specific MAPK phosphatases and the control of ERK signaling in PC12 cells , 2006, Journal of molecular signaling.

[179]  R. Lai,et al.  Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. , 2006, Blood.

[180]  Marc A. Thomas,et al.  Cardiac sodium channel Na(v)1.5 interacts with and is regulated by the protein tyrosine phosphatase PTPH1. , 2006, Biochemical and biophysical research communications.

[181]  S. Knapp,et al.  MAPK-specific tyrosine phosphatases: new targets for drug discovery? , 2006, Trends in pharmacological sciences.

[182]  S. Castiglioni,et al.  The tyrosine phosphatase HD-PTP is regulated by FGF-2 through proteasome degradation. , 2006, Frontiers in bioscience : a journal and virtual library.

[183]  Z. Zhao,et al.  Antagonism or Synergism , 2006, Journal of Biological Chemistry.

[184]  Martin Zacharias,et al.  Sequence Specificity of SHP-1 and SHP-2 Src Homology 2 Domains , 2006, Journal of Biological Chemistry.

[185]  K. Nikolich,et al.  Regulation of NMDA receptor trafficking and function by striatal‐enriched tyrosine phosphatase (STEP) , 2006, The European journal of neuroscience.

[186]  Q. Tao,et al.  Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter , 2006, Leukemia.

[187]  G. Delsol,et al.  SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling. , 2006, Blood.

[188]  A. Orth,et al.  Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling. , 2006, Cell metabolism.

[189]  K. Siminovitch,et al.  The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis , 2006, Nature Medicine.

[190]  C. Chi,et al.  PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. , 2006, Anticancer research.

[191]  N. Bottini,et al.  Lipid Raft Targeting of Hematopoietic Protein Tyrosine Phosphatase by Protein Kinase C θ-Mediated Phosphorylation , 2006, Molecular and Cellular Biology.

[192]  Ding‐Shinn Chen,et al.  Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[193]  U. Pagotto,et al.  Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. , 2006, Cancer research.

[194]  Z. Ronai,et al.  Opposite Roles of FAP-1 and Dynamin in the Regulation of Fas (CD95) Translocation to the Cell Surface and Susceptibility to Fas Ligand-mediated Apoptosis* , 2006, Journal of Biological Chemistry.

[195]  T. Sugiyama,et al.  Fas‐associated phosphatase‐1 promotes Fas‐mediated apoptosis in human colon cancer cells: Novel function of FAP‐1 , 2006, Journal of gastroenterology and hepatology.

[196]  Yan Wang,et al.  Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[197]  C. McKerlie,et al.  Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function , 2005, The Journal of experimental medicine.

[198]  A. Poole,et al.  A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. , 2005, Cellular signalling.

[199]  K. Nikolich,et al.  FAS Associated Phosphatase (FAP-1) Blocks Apoptosis of Astrocytomas through Dephosphorylation of FAS , 2005, Journal of Neuro-Oncology.

[200]  K. Mitani,et al.  Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13). , 2005, Cancer research.

[201]  B. Kemp,et al.  Protein tyrosine phosphatase hPTPN20a is targeted to sites of actin polymerization. , 2005, The Biochemical journal.

[202]  A. Bottoni,et al.  SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma. , 2005, Endocrinology.

[203]  M. Berry,et al.  Effects of LAR and PTP‐BL phosphatase deficiency on adult mouse retinal cells activated by lens injury , 2005, The European journal of neuroscience.

[204]  A. Üren,et al.  PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis , 2005, Oncogene.

[205]  M. Pierotti,et al.  Analysis of SHP-1-mediated Down-regulation of the TRK-T3 Oncoprotein Identifies Trk-fused Gene (TFG) as a Novel SHP-1-interacting Protein* , 2005, Journal of Biological Chemistry.

[206]  A. Gazdar,et al.  Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors , 2005, Oncogene.

[207]  E. Song,et al.  Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer , 2004, British Journal of Cancer.

[208]  J. Fransen,et al.  Characterization of multiple transcripts and isoforms derived from the mouse protein tyrosine phosphatase gene Ptprr , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[209]  F. Oerlemans,et al.  Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity. , 2004, Physiological genomics.

[210]  G. Rassidakis,et al.  Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma. , 2004, Blood.

[211]  N. Bottini,et al.  Control of vesicle fusion by a tyrosine phosphatase , 2004, Nature Cell Biology.

[212]  Y. Kwong,et al.  SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. , 2004, Blood.

[213]  A. Ullrich,et al.  Mitochondrial AKAP121 Binds and Targets Protein Tyrosine Phosphatase D1, a Novel Positive Regulator of src Signaling , 2004, Molecular and Cellular Biology.

[214]  Giovanni Parmigiani,et al.  Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.

[215]  Marcus Buschbeck,et al.  Negative Regulation of HER2 Signaling by the PEST-type Protein-tyrosine Phosphatase BDP1* , 2004, Journal of Biological Chemistry.

[216]  M. Zacharias,et al.  Effective Dephosphorylation of Src Substrates by SHP-1* , 2004, Journal of Biological Chemistry.

[217]  Geerten W Vuister,et al.  A closed binding pocket and global destabilization modify the binding properties of an alternatively spliced form of the second PDZ domain of PTP-BL. , 2004, Structure.

[218]  Nunzio Bottini,et al.  Haematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T-cells: dynamics and subcellular location. , 2004, The Biochemical journal.

[219]  R. Aebersold,et al.  PTPH1 Is a Predominant Protein-tyrosine Phosphatase Capable of Interacting with and Dephosphorylating the T Cell Receptor ζ Subunit* , 2004, Journal of Biological Chemistry.

[220]  R. Rottapel,et al.  A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. , 2004, Blood.

[221]  L. Diehl,et al.  PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells , 2004, Science.

[222]  A. Godzik,et al.  Homotypic Secretory Vesicle Fusion Induced by the Protein Tyrosine Phosphatase MEG2 Depends on Polyphosphoinositides in T Cells1 , 2003, The Journal of Immunology.

[223]  Z. Zhao,et al.  PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells. , 2003, Blood.

[224]  K. Siminovitch,et al.  SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase , 2003, The Journal of cell biology.

[225]  P. Lombroso,et al.  Receptor and nonreceptor protein tyrosine phosphatases in the nervous system , 2003, Cellular and Molecular Life Sciences CMLS.

[226]  L. Shih,et al.  Characterization of a Myeloid Tyrosine Phosphatase, Lyp, and Its Role in the Bcr-Abl Signal Transduction Pathway* , 2003, Journal of Biological Chemistry.

[227]  W. Hendriks,et al.  PDZ domains – glue and guide , 2003, Molecular Biology Reports.

[228]  B. Neel,et al.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. , 2003, Trends in biochemical sciences.

[229]  S. Emr,et al.  Bro1 is an endosome-associated protein that functions in the MVB pathway in Saccharomyces cerevisiae , 2003, Journal of Cell Science.

[230]  R. Pulido,et al.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. , 2003, The Biochemical journal.

[231]  Z. Ronai,et al.  FAP-1 Association with Fas (Apo-1) Inhibits Fas Expression on the Cell Surface , 2003, Molecular and Cellular Biology.

[232]  A. Ullrich,et al.  Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone. , 2003, Molecular endocrinology.

[233]  Z. Zhao,et al.  Crystal Structure of Human Protein-tyrosine Phosphatase SHP-1* , 2003, The Journal of Biological Chemistry.

[234]  W. Lu,et al.  The Role of C-terminal Tyrosine Phosphorylation in the Regulation of SHP-1 Explored via Expressed Protein Ligation* , 2003, The Journal of Biological Chemistry.

[235]  R. Herbst,et al.  The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells , 2003, Leukemia.

[236]  C. Prébois,et al.  Protein-tyrosine Phosphatase PTPL1/FAP-1 Triggers Apoptosis in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[237]  K. Hayashi,et al.  Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. , 2002, Cancer research.

[238]  C. Blobel,et al.  Evidence for Regulation of the Tumor Necrosis Factor α-Convertase (TACE) by Protein-tyrosine Phosphatase PTPH1* , 2002, The Journal of Biological Chemistry.

[239]  A. Parle‐McDermott,et al.  Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization , 2002, Oncogene.

[240]  M. Emi,et al.  Head-to-head juxtaposition of Fas-associated phosphatase-1 (FAP-1) and c-Jun NH2-terminal kinase 3 (JNK3) genes: genomic structure and seven polymorphisms of the FAP-1 gene , 2002, Journal of Human Genetics.

[241]  P. Lombroso,et al.  Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420* , 2002, The Journal of Biological Chemistry.

[242]  T. Mustelin,et al.  Enlargement of Secretory Vesicles by Protein Tyrosine Phosphatase PTP-MEG2 in Rat Basophilic Leukemia Mast Cells and Jurkat T Cells1 , 2002, The Journal of Immunology.

[243]  M. Zimmer,et al.  EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. , 2002, Molecular cell.

[244]  Geerten W Vuister,et al.  Structure, dynamics and binding characteristics of the second PDZ domain of PTP-BL. , 2002, Journal of Molecular Biology.

[245]  A. Tanswell,et al.  Protein-tyrosine Phosphatase MEG2 Is Expressed by Human Neutrophils , 2002, The Journal of Biological Chemistry.

[246]  P G Drake,et al.  Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.

[247]  A. Ullrich,et al.  Inhibition of Ret Oncogene Activity by the Protein Tyrosine Phosphatase SHP1. , 2001, Endocrinology.

[248]  B. Zanke,et al.  Hematopoietic Protein Tyrosine Phosphatase Suppresses Extracellular Stimulus-Regulated Kinase Activation , 2001, Molecular and Cellular Biology.

[249]  U. Lorenz,et al.  Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation , 2001, Leukemia.

[250]  A. Scheidig,et al.  Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation. , 2001, Journal of molecular biology.

[251]  H. Kalthoff,et al.  FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. , 2001, Journal of cell science.

[252]  S. Kellie,et al.  A Functional Nuclear Localization Sequence in the C-terminal Domain of SHP-1* , 2001, The Journal of Biological Chemistry.

[253]  X. Zhao,et al.  Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements. , 2001, Gene.

[254]  D. Scudiero,et al.  Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. , 2001, The American journal of pathology.

[255]  S. Tsai,et al.  SH2 Domain-Mediated Interaction of Inhibitory Protein Tyrosine Kinase Csk with Protein Tyrosine Phosphatase-HSCF , 2001, Molecular and Cellular Biology.

[256]  H. Kitagawa,et al.  Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway. , 2001, International journal of oncology.

[257]  W. Birchmeier,et al.  Negative Regulation of Ros Receptor Tyrosine Kinase Signaling , 2001, The Journal of cell biology.

[258]  H. Hsu,et al.  Mutation of the Hematopoietic Cell Phosphatase (Hcph) Gene Is Associated with Resistance to γ-Irradiation-Induced Apoptosis in Src Homology Protein Tyrosine Phosphatase (SHP)-1-Deficient “Motheaten” Mutant Mice1 , 2001, The Journal of Immunology.

[259]  L. Deaven,et al.  Identification of Two Fas-Associated Phosphatase-1 (FAP-1) Promoters in Human Cancer Cells , 2001, DNA sequence : the journal of DNA sequencing and mapping.

[260]  K. Lee,et al.  Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells , 2000, Experimental & molecular medicine.

[261]  H. Shih,et al.  Protein-tyrosine Phosphatase D1, a Potential Regulator and Effector for Tec Family Kinases* , 2000, The Journal of Biological Chemistry.

[262]  S. Toyooka,et al.  HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3. , 2000, Biochemical and biophysical research communications.

[263]  K. Siminovitch,et al.  Deficiency of Src Homology 2-Containing Phosphatase 1 Results in Abnormalities in Murine Neutrophil Function: Studies in Motheaten Mice1 , 2000, The Journal of Immunology.

[264]  R. Blamey,et al.  Up‐regulation of the protein tyrosine phosphatase SHP‐1 in human breast cancer and correlation with GRB2 expression , 2000, International journal of cancer.

[265]  D. Pei,et al.  Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library. , 2000, Biochemistry.

[266]  P. Peterlongo,et al.  RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. , 2000, Human molecular genetics.

[267]  J. Gamble,et al.  Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation. , 2000, Journal of cell science.

[268]  J. Mukai,et al.  Negative regulation of Fas‐mediated apoptosis by FAP‐1 in human cancer cells , 2000, International journal of cancer.

[269]  K. Siminovitch,et al.  Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. , 2000, Seminars in immunology.

[270]  A. Alonso,et al.  Subcellular localization of intracellular protein tyrosine phosphatases in T cells , 2000, European journal of immunology.

[271]  T. Maudelonde,et al.  Semiquantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway. , 2000, Journal of molecular endocrinology.

[272]  K. Hirokawa,et al.  Expression of protein tyrosine phosphatases and its significance in esophageal cancer. , 2000, Experimental and molecular pathology.

[273]  M. Mishina,et al.  The Protein-tyrosine Phosphatase PTPMEG Interacts with Glutamate Receptor δ2 and ε Subunits* , 2000, The Journal of Biological Chemistry.

[274]  T. Mustelin,et al.  Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling , 2000, European journal of immunology.

[275]  L. Mayo,et al.  Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation* , 2000, The Journal of Biological Chemistry.

[276]  Carmen Blanco-Aparicio,et al.  A Novel Regulatory Mechanism of Map Kinases Activation and Nuclear Translocation Mediated by Pka and the Ptp-Sl Tyrosine Phosphatase , 1999, The Journal of cell biology.

[277]  M. Tomonaga,et al.  Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production. , 1999, Cancer letters.

[278]  Tomas Mustelin,et al.  Characterization of TCR‐induced receptor‐proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP , 1999, European journal of immunology.

[279]  J. Baker,et al.  Characterization of FAP-1 expression and function in thyroid follicular cells. , 1999, Endocrinology.

[280]  J. Fransen,et al.  The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP‐SL and PTPBR7, that display distinct patterns of expression during neural development , 1999, The European journal of neuroscience.

[281]  J. Fujita,et al.  Expression of protein tyrosine phosphatase PTP‐RL10 and its isoform in the mouse testis , 1999, International journal of urology : official journal of the Japanese Urological Association.

[282]  John Calvin Reed,et al.  Functional interaction of Fas‐associated phosphatase‐1 (FAP‐1) with p75NTR and their effect on NF‐κB activation , 1999, FEBS letters.

[283]  S. Burakoff,et al.  Human 70-kDa SHP-1L Differs from 68-kDa SHP-1 in Its C-terminal Structure and Catalytic Activity* , 1999, Journal of Biological Chemistry.

[284]  E. Cuppen,et al.  A FERM domain governs apical confinement of PTP-BL in epithelial cells. , 1999, Journal of cell science.

[285]  O. Zschörnig,et al.  Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation. , 1999, Biochemistry.

[286]  H. Broxmeyer,et al.  Abnormal Chemokine-Induced Responses of Immature and Mature Hematopoietic Cells from Motheaten Mice Implicate the Protein Tyrosine Phosphatase Shp-1 in Chemokine Responses , 1999, The Journal of experimental medicine.

[287]  Tomas Mustelin,et al.  Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase , 1999, Nature Cell Biology.

[288]  P. Venugopal,et al.  Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows. , 1999, International journal of hematology.

[289]  K. Imai,et al.  Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase. , 1999, Journal of immunology.

[290]  A. Okuyama,et al.  Regulation of Phosphorylation Level and Distribution of PTP36, a Putative Protein Tyrosine Phosphatase, by Cell-Substrate Adhesion* , 1999, The Journal of Biological Chemistry.

[291]  K. Takagi,et al.  Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. , 1999, The American journal of pathology.

[292]  R. Kobayashi,et al.  Identification of the Cell Cycle Regulator VCP (p97/CDC48) as a Substrate of the Band 4.1-related Protein-tyrosine Phosphatase PTPH1* , 1999, The Journal of Biological Chemistry.

[293]  G. Rubin,et al.  PTP-ER, a novel tyrosine phosphatase, functions downstream of Ras1 to downregulate MAP kinase during Drosophila eye development. , 1999, Molecular cell.

[294]  E. Shaoul,et al.  Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.

[295]  T. Hamaoka,et al.  Inactivation of mitogen-activated protein kinases by a mammalian tyrosine-specific phosphatase, PTPBR7. , 1999, Biochemical and biophysical research communications.

[296]  H. S. Kim,et al.  Immunohistochemical localization of FAP‐1, an inhibitor of Fas‐mediated apoptosis, in normal and neoplastic human tissues , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[297]  R. Aubin,et al.  Inhibitory and Stimulatory Effects of Somatostatin on Two Human Pancreatic Cancer Cell Lines: A Primary Role for Tyrosine Phosphatase SHP-1. , 1999, Endocrinology.

[298]  J. Cloutier,et al.  Cooperative Inhibition of  T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase , 1999, The Journal of experimental medicine.

[299]  A. Ullrich,et al.  PTP‐SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal‐regulated kinases ERK1 and ERK2 by association through a kinase interaction motif , 1998, The EMBO journal.

[300]  S. Tatebe,et al.  Anti-Fas antibody-induced apoptosis in human colorectal carcinoma cell lines: role of the p53 gene , 1998, Apoptosis.

[301]  D. Kufe,et al.  Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase , 1998, Oncogene.

[302]  J Godovac-Zimmermann,et al.  Phosphotyrosine 1173 Mediates Binding of the Protein-tyrosine Phosphatase SHP-1 to the Epidermal Growth Factor Receptor and Attenuation of Receptor Signaling* , 1998, The Journal of Biological Chemistry.

[303]  T. Roach,et al.  The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages , 1998, Current Biology.

[304]  R. Graham,et al.  A Novel Putative Protein-tyrosine Phosphatase Contains a BRO1-like Domain and Suppresses Ha-ras-mediated Transformation* , 1998, The Journal of Biological Chemistry.

[305]  A. Ullrich,et al.  Characterization of KIF1C, a New Kinesin-like Protein Involved in Vesicle Transport from the Golgi Apparatus to the Endoplasmic Reticulum* , 1998, The Journal of Biological Chemistry.

[306]  T. Mustelin,et al.  Negative Regulation of T Cell Antigen Receptor Signal Transduction by Hematopoietic Tyrosine Phosphatase (HePTP)* , 1998, The Journal of Biological Chemistry.

[307]  Y. Komada,et al.  Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells. , 1998, Cellular immunology.

[308]  J. Houghton,et al.  Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells , 1998, Cell Death and Differentiation.

[309]  Duc Hung Le,et al.  SHP-1 Binds and Negatively Modulates the c-Kit Receptor by Interaction with Tyrosine 569 in the c-Kit Juxtamembrane Domain , 1998, Molecular and Cellular Biology.

[310]  G. Freiss,et al.  Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells. , 1998, Molecular endocrinology.

[311]  M. Matsuoka,et al.  Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. , 1998, AIDS research and human retroviruses.

[312]  Zhenbao Yu,et al.  SHP-1 Associates with Both Platelet-derived Growth Factor Receptor and the p85 Subunit of Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.

[313]  S. Matsuda,et al.  Molecular Cloning and Characterization of a Novel Cytoplasmic Protein-tyrosine Phosphatase That Is Specifically Expressed in Spermatocytes* , 1997, The Journal of Biological Chemistry.

[314]  J. Houghton,et al.  The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[315]  E. Cuppen,et al.  No Evidence for Involvement of Mouse Protein-tyrosine Phosphatase-BAS-like Fas-associated Phosphatase-1 in Fas-mediated Apoptosis* , 1997, The Journal of Biological Chemistry.

[316]  R. Kobayashi,et al.  Serine Phosphorylation-dependent Association of the Band 4.1-related Protein-tyrosine Phosphatase PTPH1 with 14-3-3β Protein* , 1997, The Journal of Biological Chemistry.

[317]  U. Hellman,et al.  A Novel GTPase-activating Protein for Rho Interacts with a PDZ Domain of the Protein-tyrosine Phosphatase PTPL1* , 1997, The Journal of Biological Chemistry.

[318]  N. Vaysse,et al.  The Tyrosine Phosphatase SHP-1 Associates with the sst2 Somatostatin Receptor and Is an Essential Component of sst2-mediated Inhibitory Growth Signaling* , 1997, The Journal of Biological Chemistry.

[319]  Jill Cheng,et al.  PSTPIP: A Tyrosine Phosphorylated Cleavage Furrow–associated Protein that Is a Substrate for a PEST Tyrosine Phosphatase , 1997, The Journal of cell biology.

[320]  M. Welham,et al.  SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates. , 1997, The Journal of biological chemistry.

[321]  D. Green,et al.  Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis , 1997, The Journal of experimental medicine.

[322]  M. Solimena,et al.  STEP: a family of brain-enriched PTPs. Alternative splicing produces transmembrane, cytosolic and truncated isoforms. , 1997, European journal of cell biology.

[323]  J. Yanagisawa,et al.  The Molecular Interaction of Fas and FAP-1 , 1997, The Journal of Biological Chemistry.

[324]  A. Ullrich,et al.  Characterization of the PEST family protein tyrosine phosphatase BDP1. , 1996, Oncogene.

[325]  P. Majerus,et al.  The effect of overexpression of the protein tyrosine phosphatase PTPMEG on cell growth and on colony formation in soft agar in COS-7 cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[326]  M. Baccarini,et al.  Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway , 1996, Molecular and cellular biology.

[327]  C. Kozak,et al.  Cloning and characterization of PTP-K1, a novel nonreceptor protein tyrosine phosphatase highly expressed in bone marrow. , 1996, Oncogene.

[328]  K. Ravichandran,et al.  Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[329]  J. Cloutier,et al.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. , 1996, The EMBO journal.

[330]  K. Siminovitch,et al.  Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase , 1996, The Journal of experimental medicine.

[331]  S. Galli,et al.  Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1 , 1996, The Journal of experimental medicine.

[332]  L. Lasky,et al.  A novel protein tyrosine phosphatase expressed in lin(lo)CD34(hi)Sca(hi) hematopoietic progenitor cells. , 1996, Blood.

[333]  B. Neel,et al.  Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1 , 1996, Molecular and cellular biology.

[334]  A. Bernstein,et al.  Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1 , 1996, Nature Genetics.

[335]  E. Krebs,et al.  Positive Effect of Overexpressed Protein-tyrosine Phosphatase PTP1C on Mitogen-activated Signaling in 293 Cells (*) , 1996, The Journal of Biological Chemistry.

[336]  T. Tsuruo,et al.  Phorbol ester-resistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases. , 1995, Oncogene.

[337]  Y. Watanabe,et al.  Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase. , 1995, Gene.

[338]  A. Ullrich,et al.  Association of SH2 Domain Protein Tyrosine Phosphatases with the Epidermal Growth Factor Receptor in Human Tumor Cells , 1995, The Journal of Biological Chemistry.

[339]  S. Hockfield,et al.  Expression of PTPH1, a rat protein tyrosine phosphatase, is restricted to the derivatives of a specific diencephalic segment. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[340]  G. Mills,et al.  Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling , 1995, The Journal of experimental medicine.

[341]  R. Berkowitz,et al.  Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. , 1995, Gynecologic oncology.

[342]  R. Stocco,et al.  Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. , 1995, Genomics.

[343]  B. Gusterson,et al.  Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains. , 1995, Biochemical and biophysical research communications.

[344]  John Calvin Reed,et al.  FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.

[345]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[346]  T. Hamaoka,et al.  cDNA Cloning and Characterization of a Novel Receptor-type Protein Tyrosine Phosphatase Expressed Predominantly in the Brain (*) , 1995, The Journal of Biological Chemistry.

[347]  P. Wahle,et al.  Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[348]  B. Wieringa,et al.  A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain. , 1995, The Biochemical journal.

[349]  P. Lombroso,et al.  A Neuronal Protein Tyrosine Phosphatase Induced by Nerve Growth Factor (*) , 1995, The Journal of Biological Chemistry.

[350]  K. Siminovitch,et al.  Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function. , 1994, Clinical immunology and immunopathology.

[351]  C. Heldin,et al.  Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins. , 1994, Journal of Biological Chemistry.

[352]  R. Stocco,et al.  A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases. , 1994, The Journal of biological chemistry.

[353]  A. Ullrich,et al.  Src kinase associates with a member of a distinct subfamily of protein-tyrosine phosphatases containing an ezrin-like domain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[354]  H. Griesser,et al.  A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. , 1994, Leukemia.

[355]  K. Maekawa,et al.  Molecular cloning of a novel protein‐tyrosine phosphatase containing a membrane‐binding domain and GLGF repeats , 1994, FEBS letters.

[356]  J. Inazawa,et al.  Expression and chromosomal assignment of PTPH1 gene encoding a cytosolic protein tyrosine phosphatase homologous to cytoskeletal‐associated proteins , 1993, International journal of cancer.

[357]  J. Ihle,et al.  Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis , 1993, Molecular and cellular biology.

[358]  A. Laughon,et al.  Expanded: a gene involved in the control of cell proliferation in imaginal discs. , 1993, Development.

[359]  D. Beier,et al.  Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.

[360]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[361]  M. Isobe,et al.  Molecular cloning and chromosomal mapping of a human protein-tyrosine phosphatase LC-PTP. , 1992, Biochemical and biophysical research communications.

[362]  M. Thomas,et al.  Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences , 1992, Molecular and cellular biology.

[363]  P. Majerus,et al.  Cloning and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to retinaldehyde-binding protein and yeast SEC14p. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[364]  M. Minden,et al.  Cloning and expression of an inducible lymphoid‐specific, protein tyrosine phosphatase (HePTPase) , 1992, European journal of immunology.

[365]  P. Lombroso,et al.  Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[366]  Peter J. Bryant,et al.  The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions , 1991, Cell.

[367]  N. Tonks,et al.  Isolation of a cDNA clone encoding a human protein-tyrosine phosphatase with homology to the cytoskeletal-associated proteins band 4.1, ezrin, and talin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[368]  J. York,et al.  Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[369]  W. Hendriks,et al.  Non-transmembrane PTPs in Cancer , 2016 .

[370]  M. Gupta,et al.  Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy , 2014, Leukemia.

[371]  O. Abaan,et al.  Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1. , 2013, Experimental cell research.

[372]  Wei Wang,et al.  Incidence and prognostic value of multiple gene promoter methylations in gliomas , 2013, Journal of Neuro-Oncology.

[373]  杉山 宏和.  Interaction of Necl-4/CADM4 with ErbB3 and integrin α₆β₄ and inhibition of ErbB2/ErbB3 signaling and hemidesmosome disassembly , 2013 .

[374]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[375]  D. Chalbos,et al.  PTPN13/PTPL1: an important regulator of tumor aggressiveness. , 2011, Anti-cancer agents in medicinal chemistry.

[376]  Iu V Kondrakhin,et al.  [Prediction of a non-small cell lung cancer sensitivity to cisplatin and paclitaxel based on the marker genes expression]. , 2011, Molekuliarnaia biologiia.

[377]  W. Birchmeier,et al.  The tyrosine phosphatase Shp2 in development and cancer. , 2010, Advances in cancer research.

[378]  河野 智.  Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2 , 2010 .

[379]  C. Patrignani,et al.  Research of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation , 2010 .

[380]  T. Whiteside,et al.  FAP‐1‐mediated activation of NF‐κB induces resistance of head and neck cancer to fas‐induced apoptosis , 2007, Journal of cellular biochemistry.

[381]  Jiahuai Han,et al.  Essential role of p38gamma in K-Ras transformation independent of phosphorylation. , 2005, The Journal of biological chemistry.

[382]  G. W. Vuister,et al.  The interaction of PTP-BL PDZ domains with RIL: An enigmatic role for the RIL LIM domain , 2005, Molecular Biology Reports.

[383]  A. Pandey,et al.  A bioinformatics analysis of protein tyrosine phosphatases in humans. , 2005, DNA research : an international journal for rapid publication of reports on genes and genomes.

[384]  W. Marasco,et al.  Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells. , 2004, Leukemia research.

[385]  T. Dittmar,et al.  The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis. , 2003, Molecular biology of the cell.

[386]  J. Gamble,et al.  The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. , 2003, Molecular biology of the cell.

[387]  N. Bucay,et al.  Protein tyrosine phosphatase (PC12, Br7,S1) family: expression characterization in the adult human and mouse. , 2000, The Anatomical record.

[388]  Eric O Long,et al.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.

[389]  澤田 元幸.  cDNA cloning of a novel protein tyrosine phosphatase with homology to cytoskeletal protein 4.1 and its expression in T-lineage cells , 1995 .

[390]  J. Cyster,et al.  Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. , 1995, Immunity.

[391]  N. Kley,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. , 1993, Cell.